We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$38.7B
AUM Growth
+$2.08B
Cap. Flow
+$138M
Cap. Flow %
0.36%
Top 10 Hldgs %
12.49%
Holding
800
New
128
Increased
207
Reduced
303
Closed
113

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$378M
2
BA icon
Boeing
BA
+$329M
3
BAC icon
Bank of America
BAC
+$264M
4
GE icon
GE Aerospace
GE
+$190M
5
PPL
PPL Corp
PPL
+$184M

Sector Composition

Rank Sector Weight
1 Healthcare 15.01%
2 Technology 11.8%
3 Industrials 10.62%
4 Financials 10.57%
5 Energy 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTLK
626
DELISTED
Datalink Corp
DTLK
$3.5M 0.01%
+350,000
New +$3.81M
ENT
627
DELISTED
Global Eagle Entertainment Inc.
ENT
$3.38M 0.01%
10,886
-7,514
-41% -$2.23M
E icon
628
ENI
E
$77.9B
$3.29M 0.01%
60,000
RDC
629
DELISTED
Rowan Companies Plc
RDC
$3.28M 0.01%
102,651
-26,149
-20% -$819K
LDRH
630
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$3.25M 0.01%
+129,946
New +$3.28M
HSKA
631
DELISTED
Heska Corp
HSKA
$3.23M 0.01%
300,001
+50,000
+20% +$552K
MGNI icon
632
Magnite
MGNI
$2.83B
$3.21M 0.01%
+250,000
New +$3.75M
UNM icon
633
Unum
UNM
$13.6B
$3.12M 0.01%
89,602
-302,200
-77% -$10.3M
CASC
634
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.08M 0.01%
158,333
CYN
635
DELISTED
CITY NATIONAL CORPORATION
CYN
$2.96M 0.01%
+39,000
New +$2.89M
NXTM
636
DELISTED
NxStage Medical Inc.
NXTM
$2.87M 0.01%
200,000
+150,000
+300% +$1.96M
THR
637
DELISTED
Thermon Group Holdings
THR
$2.86M 0.01%
108,558
CS
638
DELISTED
Credit Suisse Group
CS
$2.84M 0.01%
+100,000
New +$3.06M
SB icon
639
Safe Bulkers
SB
$796M
$2.83M 0.01%
290,204
QUOT
640
DELISTED
Quotient Technology Inc
QUOT
$2.76M 0.01%
+105,000
New +$2.34M
XPRO icon
641
Expro Ltd
XPRO
$1.81B
$2.6M 0.01%
17,635
+8,333
+90% +$1.23M
RRC icon
642
Range Resources
RRC
$9.09B
$2.54M 0.01%
29,200
-34,100
-54% -$3.05M
RJF icon
643
Raymond James Financial
RJF
$33.7B
$2.54M 0.01%
+75,000
New +$2.5M
CMP icon
644
Compass Minerals
CMP
$1.23B
$2.42M 0.01%
+25,253
New +$2.28M
VRSN icon
645
VeriSign
VRSN
$25.8B
$2.39M 0.01%
48,990
-5,500
-10% -$274K
PBI icon
646
Pitney Bowes
PBI
$2.41B
$2.22M 0.01%
+80,317
New +$2.14M
RIGL icon
647
Rigel Pharmaceuticals
RIGL
$717M
$2.18M 0.01%
60,000
-40,000
-40% -$1.36M
WMB icon
648
Williams Companies
WMB
$86.5B
$2.16M 0.01%
37,090
-1,017,900
-96% -$47.2M
MTEM
649
DELISTED
Molecular Templates, Inc.
MTEM
$2.12M 0.01%
3,251
FNFG
650
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$1.97M 0.01%
+225,000
New +$1.99M

Similar funds

Adage Capital Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Adage Capital Partners held 800 positions worth $38.7B, up 5.7% from $36.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Adage Capital Partners's Q2 2014 filing shows 128 new, 207 increased, 303 reduced and 113 closed positions. Its largest new stake was Bank of America: 17,027,186 shares worth $262M. The largest sale was Illinois Tool Works, an estimated $279M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Adage Capital Partners's largest Q2 2014 buy was Bank of America: 17,027,186 shares worth $262M.
  • Adage Capital Partners added most to QUESTCOR PHARMA INC in Q2 2014, an estimated $378M increase.
  • Adage Capital Partners's biggest Q2 2014 reduction was Illinois Tool Works, cutting an estimated $279M.
  • Adage Capital Partners fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $221M.
  • Adage Capital Partners's ten largest holdings make up 12% of its $38.7B portfolio in Q2 2014.
  • Adage Capital Partners opened 128 new positions and closed 113 in Q2 2014.
  • Adage Capital Partners's portfolio value rose 5.7% quarter-over-quarter to $38.7B.

Based on Adage Capital Partners's 13F filing for Q2 2014, filed 14 Aug 2014.